Remicade (infliximab) is a prescription drug that’s used to treat certain autoimmune conditions. This drug can interact with certain vaccines and other medications, such as immunosuppressant ...
Johnson & Johnson has come out fighting after Pfizer announced yesterday that it is ready to launch a biosimilar competitor to its blockbuster Remicade. J&J said it had a “biosimilar ...
JAKARTA: Indonesia President Prabowo Subianto has hit back at recent “Dark Indonesia” protests in the country, depicting a bright future as he expressed confidence that the archipelago would ...
JAKARTA: At least seven international flights from Indonesia's resort island Bali have been cancelled, an airport official said on Friday (Mar 21), after a volcano in the archipelago nation's ...
Indonesia has started replacing diesel as a fuel in dozens of power plants with LNG, which is set to boost demand for natural gas in one of the world’s top LNG exporters. Following a decade of ...
Indonesia’s parliament on Thursday passed contentious revisions to the country’s military law, which will allocate more civilian posts for military officers, and street protests against the ...
JAKARTA/MUMBAI, March 17 (Reuters) - Indonesia's crude and refined palm oil exports surged 62.2% in February from a month ago to reach a four-month high, the statistics bureau said on Monday ...
JAKARTA, March 14 (Reuters) - Indonesia plans to launch sales of carbon offsets from its forestry sector soon, while authorities work on recognising existing international standards, state news ...
United Nations special rapporteurs have singled out Indonesia’s second-largest palm oil company, PT Astra Agro Lestari (AAL), for alleged human rights violations and environmental degradation ...
Celltrion developed and manufactured the world’s first monoclonal antibody biosimilar, followed by the first and only subcutaneous (SC) formulation infliximab, ‘Remsima ® SC’, which was ...
Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Healthcare, Oil & Gas and Technology sectors ...